Health Canada is reviewing AstraZeneca and Oxford University’s COVID-19 vaccine for use, and Johnson & Johnson’s shot may be close behind. Crystal Goomansingh looks at how each candidate compares to the shots from Pfizer/BioNTech and Moderna, amid an urgent need for more vaccines.
- AstraZeneca’s coronavirus vaccine may reduce virus transmission, developers say
- Oxford-AstraZeneca didn’t tell vaccine trial volunteers about dosing mishap
- Canada’s vaccine rollout faces criticism as country enters 11th month of pandemic life